期刊文献+

基于嘌呤配体P2X门控离子通道型受体7的资生肾气丸镇痛机制研究

Zisheng Shenqi Pills Relieve Pain via Purinergic Receptor P2X,Ligand-gated Ion Channel 7
下载PDF
导出
摘要 目的:探索资生肾气丸对醋酸致小鼠扭体模型的镇痛作用。方法:将42只小鼠随机分为7组,分别给予相应药液灌胃,末次灌胃1 h后造模,建立醋酸致小鼠扭体模型。观察小鼠扭体次数,计算其扭体抑制率,应用酶联免疫吸附试验(ELISA)检测各组小鼠血清白细胞介素-1β(IL-1β)、前列腺素E 2(PGE 2)、神经生长因子(NGF)含量,采用实时PCR(RT-PCR)检测嘌呤配体P2X门控离子通道型受体7(P2X7R)mRNA、Nod样受体蛋白3(NLRP3)mRNA、NIMA相关激酶7(NEK7)mRNA的表达情况。结果:与模型组比较,随着时间的增加,资生肾气丸低剂量、中剂量、高剂量均可抑制小鼠扭体反应,降低扭体次数,增加小鼠扭体抑制率,降低小鼠血清中IL-1β、PGE_(2)、NGF的含量,降低P2X7RmRNA、NLRP3mRNA、NEK7mRNA的表达以抑制疼痛反应,以高剂量效果最优(P<0.05),与吲哚美辛、痛风舒片疗效相近。结论:资生肾气丸高剂量对小鼠血清疼痛因子的降低效果显著,其机制可能与嘌呤配体P2X门控离子通道型受体7信号通路有关。 Objective:To explore the pain-relieving effect of Zisheng Shenqi Pills on the mouse model of writhing induced by acetic acid.Methods:Forty-two mice were randomized into 7 groups and administrated with corresponding drug solutions by gavage.The model was established 1 h after the last administration.The writhing times of mice were observed,and the writhing inhibition rate was calculated.The enzyme-linked immunosorbent assay(ELISA)was employed to measure the levels of interleukin-1β(IL-1β),prostaglandin E 2(PGE 2),and nerve growth factor(NGF)in the serum.The mRNA levels of purinergic receptor P2X,ligand-gated ion channel 7(P2X7R),Nod-like receptor protein 3(NLRP3),and NIMA-related kinase 7(NEK7)were determined by RT-PCR.Results:Compared with the model group,Zisheng Shenqi Pills at low,medium,and high doses inhibited the writhing response,reduced the writhing times,increased the inhibition rate of writhing,and lowered the levels of IL-1β,PGE_(2),and NGF in the serum of mice.Moreover,they down-regulated the mRNA levels of P2X7R,NLRP3,and NEK7 to inhibit the pain response.The high dose group demonstrated the best effect(P<0.05),which was similar to that of indometacin and Tongfengshu Tablets.Conclusion:Zisheng Shenqi Pills at high doses can significantly lower the levels of pain factors in the serum of mice by regulating the P2X7R signaling pathway.
作者 李文昊 任鹏鹏 韩洁茹 常佳怡 解颖 陈飞 李富震 姜德友 LI Wenhao;REN Pengpeng;HAN Jieru;CHANG Jiayi;XIE Ying;CHEN Fei;LI Fuzhen;JIANG Deyou(Heilongjiang University of Chinese Medicine,Harbin 150040,China;Department of Integrated Chinese and Western Medicine,The First Affiliated Hospital of Harbin Medical University,Harbin 150000,China)
出处 《世界中医药》 CAS 2023年第17期2452-2456,共5页 World Chinese Medicine
基金 黑龙江省中医药科研项目(ZYW2022-047) 黑龙江中医药大学校基金项目(201733) 黑龙江中医药大学基础医学院青年教师科研资助项目(JCQNZR-Ⅱ-05)。
关键词 资生肾气丸 镇痛机制 嘌呤配体P2X门控离子通道型受体7 Nod样受体蛋白3 NIMA相关激酶7 前列腺素E 2 白细胞介素-1β 痛风性关节炎 Zisheng Shenqi Pills Pain-relieving mechanism purinergic receptor P2X,ligand-gated ion channel 7 Nod-like receptor protein 3 NIMA-related kinase 7 Prostaglandin E 2 Interleukin-1β Gouty arthritis
  • 相关文献

参考文献12

二级参考文献119

共引文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部